ThePeptideList's banner

ThePeptideList

@PeptideList • 12,733 subscribers

Founder of ThePeptideList building on X.

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

Jeremy Renner casually listing peptides tells you where this market is going. Thymosin. BPC-157. MOTS-c. TB-500. NAD. Hormones. The celebrity stack gets attention. The biology decides whether it makes sense. Same peptide. Different body.

Jeremy Renner casually listing peptides tells you where this market is going. Thymosin. BPC-157. MOTS-c. TB-500. NAD. Hormones. The celebrity stack gets attention. The biology decides whether it makes sense. Same peptide. Different body.

334,710 Aufrufe • vor 3 Monaten

90 days ago I launched The Peptide List from my apartment with zero funding, zero team, and zero followers on this app. Today: $~30K revenue. 33,000 visitors. 7,000 of you following along. A sold-out research cohort. An iOS app. A genetics engine with 400K data points. All organic. All word of mouth. I'm not going to lie I didn't expect this. I hoped, but I didn't expect it. The part that gets me isn't the numbers. It's the DMs. The providers who told me this is the resource they've been waiting for. The people who bought a DNA kit and actually changed what they're taking based on their results. The strangers on here who became real connections. Building in public is terrifying and addicting at the same time. You see everything the wins, the 2am debugging sessions, the days where nothing works. But you also get to share moments like this one with people who actually care. I'm raising a seed round now to scale this properly. But honestly? Even if the next 90 days were exactly like the first 90, I'd still be the happiest guy in the room. DM or: investors@tplgenetics.com

90 days ago I launched The Peptide List from my apartment with zero funding, zero team, and zero followers on this app. Today: $~30K revenue. 33,000 visitors. 7,000 of you following along. A sold-out research cohort. An iOS app. A genetics engine with 400K data points. All organic. All word of mouth. I'm not going to lie I didn't expect this. I hoped, but I didn't expect it. The part that gets me isn't the numbers. It's the DMs. The providers who told me this is the resource they've been waiting for. The people who bought a DNA kit and actually changed what they're taking based on their results. The strangers on here who became real connections. Building in public is terrifying and addicting at the same time. You see everything the wins, the 2am debugging sessions, the days where nothing works. But you also get to share moments like this one with people who actually care. I'm raising a seed round now to scale this properly. But honestly? Even if the next 90 days were exactly like the first 90, I'd still be the happiest guy in the room. DM or: [email protected]

54,816 Aufrufe • vor 4 Monaten

This is the Reta conversation everyone is about to have. Triple agonist. Weight loss. Fat burning. Muscle preservation. Not FDA-approved yet. Already everywhere.

This is the Reta conversation everyone is about to have. Triple agonist. Weight loss. Fat burning. Muscle preservation. Not FDA-approved yet. Already everywhere.

18,193 Aufrufe • vor 3 Monaten

I built a pharmacogenomics engine that matches your DNA to the right peptides. 827 providers. 102 peptides. 54,000 evidence chains. An iOS app. A knowledge graph validated against clinical standards. $1,300 in sales. No team. No funding. Just fumes. Looking for angels who get it. DM me.

I built a pharmacogenomics engine that matches your DNA to the right peptides. 827 providers. 102 peptides. 54,000 evidence chains. An iOS app. A knowledge graph validated against clinical standards. $1,300 in sales. No team. No funding. Just fumes. Looking for angels who get it. DM me.

25,883 Aufrufe • vor 4 Monaten

Keine weiteren Inhalte verfügbar